The latest board meeting for Xeris Biopharma Holdings Inc took place on 08 Aug 2025, for the purpose of Xeris Biopharma Holdings Inc Second Quarter Earnings Results for 2025See details
Xeris Biopharma Holdings Inc has a share price target of US$ 8, revenue growth forecast of 38.6%, and profit growth estimate of 86.1% for FY25, based on top 5 analyst calls.